Texas Biomed creating variant-specific COVID-19 treatments

Pfizer starting trials to create vaccine specific to omicron variantПодробнее

Interview with Dr. Larry Schlesinger, Texas Biomed CEO, on COVID-19 vaccineПодробнее

Texas Biomedical Research Institute studying Omicron variant, urges vaccinesПодробнее

Texas Biomed 2021 Global Health SymposiumПодробнее

COVID-19 ProjectsПодробнее

Predictions COVID-19 vaccine ready this fall ‘unrealistic,’ Texas Biomed CEO saysПодробнее

Predicting PandemicsПодробнее

Texas Biomed teams up with scientists across the country to fight coronavirusПодробнее

Texas BioMed CEO reflects on its crucial role in vaccine developmentПодробнее

Texas Biomed Unraveling The Mysteries Of Infectious DiseasesПодробнее

The Role of Innovation in Addressing PandemicsПодробнее

The San Antonio ties to the medication President Trump used following COVID-19 diagnosisПодробнее

Texas Biomed to expand facilities, bring new jobs to San AntonioПодробнее

Golden Circle COVID19 BriefingПодробнее

KSAT Explains debrief: Work at Texas Biomedical Research Institute has provided hope amid pandemicПодробнее

Coronavirus: Discussion & OverviewПодробнее

COVID19 and BeyondПодробнее

An Exclusive Look Inside the Creation of the COVID-19 VaccineПодробнее

COVID-19 Research UpdateПодробнее